Widespread Variants of the Highly Polymorphic Plasmodium falciparum Vaccine Candidate Antigen MSP2 Across Sub-Saharan Africa
Authors:
- Julia ZerebinskiJZJulia Zerebinski
- Ioanna BroumouIBIoanna Broumou
- Kelvin M KimenyiKKKelvin M Kimenyi
- Eleni AklilluEAEleni Aklillu
- Carolina M AndradeCACarolina M Andrade
- Philip BejonPBPhilip Bejon
- Mariama K CherifMCMariama K Cherif
- Peter D CromptonPCPeter D Crompton
- Cláudia FançonyCFCláudia Fançony
- José Pedro GilJGJosé Pedro Gil
Open Access
- 22 July 2026
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
Abstract
Background: A multicomponent vaccine is increasingly recognized as a necessary tool to control and eliminate malaria globally. However, genetic diversity in Plasmodium falciparum poses a significant challenge, particularly for blood-stage antigens associated with protective immunity. Individuals in endemic regions acquire clinical immunity without exposure to all antigenic variants, suggesting that a deeper understanding of antigen diversity could inform more effective vaccine strategies. Methods: The genetic diversity of the polymorphic gene locus for merozoite surface protein 2 was assessed with nested polymerase chain reaction and capillary electrophoresis fragment sizing in P falciparum isolates from 34 countries across sub-Saharan Africa. High fidelity long-read sequencing was used to investigate sequence diversity within msp2 variants. Results: We successfully genotyped msp2 from 2761 P falciparum–positive samples using capillary electrophoresis, identifying 412 distinct msp2 size variants. Several msp2 size variants were consistently overrepresented across geographical regions, transmission intensities, and time points. These variants comprised multiple unique sequences, of which several were geographically and temporally widespread. Nucleotide and amino acid sequences showed high diversity without geographical clustering. Conclusions: This study provides a comprehensive assessment of msp2 diversity across sub-Saharan Africa. The widespread prevalence of certain variants of this highly polymorphic antigen suggests possible structural constraints or selective advantages for the parasite. Maintenance of specific gene lengths and sequences across diverse settings highlights their potential as targets for next-generation, multicomponent malaria vaccines.Keywords
Funding Information
- U.S. Department of Health and Human Services
This publication has 47 references indexed in Scilit:
- A genomic platform for surveillance and antigen discovery in Plasmodium spp. using long-read amplicon sequencingCell Reports Methods, 2023
- Genotyping of Plasmodium falciparum to Assess Clone Composition in Parasite Cultures2022
- Genetic diversity of Plasmodium falciparum infections in mild and severe malaria of children from Kampala, UgandaParasitology Research, 2013
- Lipid interactions of the malaria antigen merozoite surface protein 2Biochimica et Biophysica Acta (BBA) - Biomembranes, 2012
- Plasmodium falciparum merozoite surface protein 2 is unstructured and forms amyloid-like fibrilsMolecular and Biochemical Parasitology, 2009
- A partially structured region of a largely unstructured protein, Plasmodium falciparum merozoite surface protein 2 (MSP2), forms amyloid‐like fibrilsJournal of Peptide Science, 2007
- Merozoite surface protein 2 of Plasmodium falciparum: Expression, structure, dynamics, and fibril formation of the conserved N‐terminal domainBiopolymers, 2007
- Plasmodium falciparum: Worldwide sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-2 (MSP-2)Experimental Parasitology, 2007
- Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversityInfection, Genetics and Evolution, 2007
- Extensive genetic diversity of Plasmodium falciparum isolates collected from patients with severe malaria in Dakar, SenegalTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996